The import of therapeutic respiration apparatus to China is anticipated to grow steadily, starting from $346.51 million in 2024 and reaching $384.51 million by 2028. This growth represents a consistent year-on-year increase, with a projected compound annual growth rate (CAGR) between 2024 and 2028 reflecting the healthcare sector's expansion and rising demand in China. Compared to 2023, these forecasts demonstrate a healthy growth trajectory, signaling an optimistic market outlook.

Future trends to watch for:

Increasing investment in healthcare infrastructure may drive further import growth.
Technological advancements in therapeutic respiration apparatus could enhance import value.
Policy changes in China regarding medical imports could impact market dynamics.